← Back to headlines
EU Approves New Bladder Cancer Treatment Reducing Death Risk by 50%
The European Union has approved a new combination therapy of pembrolizumab and enfortumab vedotin-ejfv for adult patients with surgically resectable bladder cancer, which has shown to reduce the risk of death by 50%.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
